Vertex Pharmaceuticals (VRTX)
(Delayed Data from NSDQ)
$465.70 USD
-18.26 (-3.77%)
Updated Nov 15, 2024 04:00 PM ET
After-Market: $466.69 +0.99 (0.21%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth C Momentum C VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 25% (72 out of 250)Zacks Sector Rank
Top 19% (3 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.91 | 1.38 | 9.99 |
Current Quarter Estimate | 4.09 | 2.15 | 63.00 |
Year Ago Quarter Estimate | 4.20 | 1.53 | 52.25 |
Next Quarter Estimate | 4.35 | 2.94 | 66.00 |
Next Year Estimate | 18.54 | 21.30 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -96.85 | 17.70 | 15.67 |
Next Year | 3,762.50 | 9.40 | 11.34 |
Last 5 Years | 38.20 | 4.00 | 8.10 |
Next 5 Years | 12.20 | 21.00 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 948.94 | -3.92 |
Price/Book (MRQ) | 7.99 | 2.11 |
Price/Cash Flow (MRFY) | 33.02 | 15.64 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -4.52% | -60.49% |
Return on Equity (TTM) | -1.91% | -44.78% |
Debt to Equity (MRQ) | 0.01 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.